Literature DB >> 30391465

Carnosine improves functional recovery and structural regeneration after sciatic nerve crush injury in rats.

Navideh Mirzakhani1, Amir Abbas Farshid2, Esmaeal Tamaddonfard3, Mehdi Imani4, Amir Erfanparast3, Farahnaz Noroozinia5.   

Abstract

AIMS: Peripheral nerve injury represents a substantial clinical problem with insufficient or unsatisfactory treatment options. Current researches have extensively focused on the new approaches for the treatment of peripheral nerve injuries. Carnosine is a naturally occurring pleotropic dipeptide and has many biological functions such as antioxidant property. In the present study, we examined the regenerative ability of carnosine after sciatic nerve crush injury using behavioral, biochemical, histological and ultrastructural evaluations.
MATERIALS AND METHODS: Seventy-two rats were divided into six groups including control, sham, crush and carnosine (10, 20 and 40 mg/kg) groups. Crush injury in left sciatic nerve was induced by a small haemostatic forceps. Carnosine was administered for 15 consecutive days after induction of crush injury. Sciatic functional index (SFI) was recorded weekly. Histopathological and ultrastructural evaluations were made using light and electron microscopes, respectively. Sciatic nerve tissue malondialdehyde (MDA), superoxide dismutase (SOD) and tumor necrosis factor-alpha (TNF-α) levels were measured. Gastrocnemius muscle weight was determined. KEY
FINDINGS: Carnosine at the doses of 20 and 40 mg/kg accelerated SFI recovery. Wallerian degeneration severity and myelinated fibers density, myelin sheath thickness and diameter as well as ultrastructural changes of myelinated axons were improved. It also recovered nerve tissue biochemical (MDA, SOD and TNF-α) changes induced by crush injury. Muscle weight ratio was reached to near normal values. Our results suggest a regenerative effect of carnosine. Inhibition of oxidative stress and inflammatory pathways, along with provocation of myelination and prevention of muscular atrophy might be involved in this effect of carnosine. SIGNIFICANCE: Carnosine treatment might be considered as a therapeutic agent for peripheral nerve regeneration and its functional recovery.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carnosine; Carnosine (Pubchem CID: 439224); Chloroform (Pubchem CID: 6212); Ethanol (Pubchem CID: 702); Formaldehyde (Pubchem CID: 712); Functional recovery; Lead citrate (Pubchem CID: 159739); Nitrobluetetrazolium (PubChem CID: 9282); Normal saline (PubChem: 5234); Osmium tetroxide (Pubchem CID: 30318); Oxidative stress; Rats; Regeneration; Sciatic nerve crush; Sodium dodecyl sulphate (Pubchem CID: 3423265); Thiobarbituric acid (Pubchem CID: 2723628); Uranyl acetate (Pubchem CID: 10915)

Mesh:

Substances:

Year:  2018        PMID: 30391465     DOI: 10.1016/j.lfs.2018.10.043

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  The effect of tropisetron on peripheral diabetic neuropathy: possible protective actions against inflammation and apoptosis.

Authors:  Amir Mohammad Ghazipour; Bagher Pourheydar; Roya Naderi
Journal:  Cell Stress Chaperones       Date:  2022-08-16       Impact factor: 3.827

2.  Balenine, Imidazole Dipeptide Promotes Skeletal Muscle Regeneration by Regulating Phagocytosis Properties of Immune Cells.

Authors:  Min Yang; Luchuanyang Sun; Yasunosuke Kawabata; Fumihito Murayama; Takahiro Maegawa; Takeshi Nikawa; Katsuya Hirasaka
Journal:  Mar Drugs       Date:  2022-05-05       Impact factor: 6.085

3.  Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye.

Authors:  Maryna Baydyuk; David S Cha; Jingwen Hu; Reiji Yamazaki; Evan M Miller; Victoria N Smith; Katherine A Kelly; Jeffrey K Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

4.  FGF10 Enhances Peripheral Nerve Regeneration via the Preactivation of the PI3K/Akt Signaling-Mediated Antioxidant Response.

Authors:  Lvpeng Dong; Rui Li; Duohui Li; Beini Wang; Yingfeng Lu; Peifeng Li; Fangzheng Yu; Yonglong Jin; Xiao Ni; Yanqing Wu; Shengnan Yang; Guanxi Lv; Xiaokun Li; Jian Xiao; Jian Wang
Journal:  Front Pharmacol       Date:  2019-10-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.